Alefacept in Patients With Severe Scalp Alopecia Areata
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine prospectively the safety and efficacy of alefacept in
the treatment of subjects with severe alopecia areata of the scalp. Common features between
psoriasis and alopecia areata, including immunologic and therapeutic aspects, suggest that
alefacept, which has been shown to be a safe and statistically significant beneficial
therapeutic modality for the treatment of psoriasis, may have therapeutic value in alopecia
areata.
Phase:
N/A
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute